BeautyBooksElectronicsHome & KitchenSports & OutdoorsIndustrial & ScientificToys & Games
Deliver toQatar
Oxford Handbook of Oncology (Oxford Medical Handbooks)

Description:

Now fully revised and in its fifth edition, the Oxford Handbook of Oncology has been the essential go-to guide for students, junior doctors, and medical professionals embarking on a career in oncology for over two decades. The handbook includes an introduction to the scientific basis and diagnosis of cancers, as well as drugs, biomarkers, and the presentation and psychosocial aspects of oncology. Concise, practical, and comprehensive, there is no better companion for both common conditions and challenging emergencies.

The field of oncology has surged forward since the last edition was published and the Oxford Handbook of Oncology has been fully revised and updated to reflect these recent advances so you can be sure that the vital information you need is in your hands. This handbook incorporates changes such as the understanding of the science of cancer, novel therapies in breast, lung, renal, and melanoma, molecular sub-classification of common solid cancers, personalized therapy approaches, new agents in hard to treat cancers, the benefits of new technologies in radiotherapy, and the increasing role of immunotherapy and targeted anti-cancer therapies.

Written by experts in the field to ensure that it is grounded in real life clinical practice, this handbook provides a concise guide to all aspects of oncology for all students, nurses, and junior faculty responsible for the care of cancer patients, while also providing further reading and highlighting areas of controversy for those who need a more detailed understanding.
Read more

Review

Review from previous edition Written by experts in the field to ensure that it is grounded in real life clinical practice, this Handbook provides a concise guide to all aspects of oncology for all students, nurses, and junior faculty responsible for the care of cancer patients, while also providing further reading and highlighting areas of controversy for those who need a more detailed understanding. ― Anticancer Research

About the Author

Miranda Payne is a previous CRUK Clinical Fellow and a current Consultant in Medical Oncology at the Oxford University Hospitals NHS Foundation Trust. Recruitment to international, academic, industry-sponsored and observational clinical trials is a routine aspect of Miranda's clinical practice, reflected in her publication record. She has a particular interest in the consequences of immunotherapy and in the systemic treatment of melanoma. She has been an editor of the Oxford Handbook of Oncology for over 20 years.


Robert Owens is a consultant clinical oncologist in Oxford where he also completed his oncology training. He specialises in treating GI cancers and has a specific interest in focussed targeted radiotherapy (SABR) especially in the upper GI setting.


Gareth Morris Stiff is an accomplished surgical oncologist with 32 years of postgraduate experience with specific expertise in hepato-pancreato-biliary (HPB) cancers, and a Pharma key opinion leader in exocrine pancreatic insufficiency. Extensive research portfolio and widely published in peer-reviewed journals. Numerous leadership roles directing teams and committees within the clinical and research arenas up to a national level. Departed clinical practice to develop anti-cancer therapies with a portfolio including antibodies, small molecules, Ayurvedic-western hybrids, and phytomedicines. Currently global chief medical officer for Equilibrium Labs developing phytomedicines to aid metabolism dysfunction-associated fatty liver disease and cancer chemotherapy-related adverse events.


Victoria Woodcock is a consultant in medical oncology specialising in the treatment of colorectal cancer. She completed her oncology training in Oxford and undertook a DPhil in Oncology at the University of Oxford studying immune responses to checkpoint inhibitor treatment in melanoma. Her academic interests include understanding and augmenting immune responses against cancer through conducting clinical trials of novel immunotherapy treatments and translational research.


Dr Rebecca Shakir is a clinical oncology consultant at the Churchill Hospital in Oxford and post-doctoral academic visitor at Oxford Population Health. Alongside treating people with head and neck and skin cancer, she specialises in the management of people with the long-term side-effects of cancer treatment. Her research focuses on determining the benefits and risks of radiotherapy and shared decision making. In addition to her clinical work, Rebecca is the Sherrington Lecturer at Magdalen College Oxford and a member of the Specialty Training and Professional Standards Boards at the Royal College of Radiologists.

Details:

Visit the Miranda Payne (Editor), Semini Greening (Editor), Robert Owens (Editor), Rebecca Shakir (Editor), Victoria Woodcock (Editor), Gareth Morris-Stiff (Editor) & 3 more Store

Oxford Handbook of Oncology (Oxford Medical Handbooks)

Product ID: K0198847165
Condition: New

QAR40711

Price includes VAT & Import Duties
Type: Paperback
Availability: In Stock

Quantity:

|

Order today to get by 7-14 business days

This item qualifies for free delivery

Returns & Warranty policies

Imported From: United Kingdom

At BOLO, we work hard to ensure the products you receive are new, genuine, and sourced from reputable suppliers.

Every product in the BOLO catalogue is sourced through our Verified Global Supply Network of verified sellers, authorized distributors or directly from the manufacturer.

Each product undergoes thorough inspection and verification at our consolidation and fulfilment centers to ensure it meets our strict authenticity and quality standards before being shipped and delivered to you.

If you ever have concerns regarding the authenticity of a product purchased from us, please contact Bolo Support. We will review your inquiry promptly and, if necessary, provide documentation verifying authenticity or offer a suitable resolution.

Your trust is our top priority, and we are committed to maintaining transparency and integrity in every transaction.

While we strive to display accurate information, variations in packaging, labeling, instructions, or formulation may occasionally occur due to regional differences or supplier updates. For detailed or manufacturer-specific information, please contact the brand directly or reach out to BOLO Support for assistance.

Unless otherwise stated, all prices displayed on the product page include applicable taxes and import duties.

BOLO operates in accordance with the laws and regulations of Qatar. Any items found to be restricted or prohibited for sale within the Qatar will be cancelled prior to shipment. We take proactive measures to ensure that only products permitted for sale in Qatar are listed on our website.

All items are shipped by air, and any products classified as “Dangerous Goods (DG)” under IATA regulations will be removed from the order and cancelled.

All orders are processed manually, and we make every effort to process them promptly once confirmed. Products cancelled due to the above reasons will be permanently removed from listings across the website.

Similar suggestions by Bolo

Share with

Or share with link

https://www.bolo.qa/products/K0198847165

Visit the Miranda Payne (Editor), Semini Greening (Editor), Robert Owens (Editor), Rebecca Shakir (Editor), Victoria Woodcock (Editor), Gareth Morris-Stiff (Editor) & 3 more Store

Oxford Handbook of Oncology (Oxford Medical Handbooks)

Product ID: K0198847165
Condition: New
Oxford Handbook of Oncology (Oxford Medical Handbooks)-0
Type: Paperback

QAR40711

Price includes VAT & Import Duties
Availability: In Stock

Quantity:

|

Order today to get by 7-14 business days

This item qualifies for free delivery

Returns & Warranty policies

Imported From: United Kingdom

At BOLO, we work hard to ensure the products you receive are new, genuine, and sourced from reputable suppliers.

Every product in the BOLO catalogue is sourced through our Verified Global Supply Network of verified sellers, authorized distributors or directly from the manufacturer.

Each product undergoes thorough inspection and verification at our consolidation and fulfilment centers to ensure it meets our strict authenticity and quality standards before being shipped and delivered to you.

If you ever have concerns regarding the authenticity of a product purchased from us, please contact Bolo Support. We will review your inquiry promptly and, if necessary, provide documentation verifying authenticity or offer a suitable resolution.

Your trust is our top priority, and we are committed to maintaining transparency and integrity in every transaction.

While we strive to display accurate information, variations in packaging, labeling, instructions, or formulation may occasionally occur due to regional differences or supplier updates. For detailed or manufacturer-specific information, please contact the brand directly or reach out to BOLO Support for assistance.

Unless otherwise stated, all prices displayed on the product page include applicable taxes and import duties.

BOLO operates in accordance with the laws and regulations of Qatar. Any items found to be restricted or prohibited for sale within the Qatar will be cancelled prior to shipment. We take proactive measures to ensure that only products permitted for sale in Qatar are listed on our website.

All items are shipped by air, and any products classified as “Dangerous Goods (DG)” under IATA regulations will be removed from the order and cancelled.

All orders are processed manually, and we make every effort to process them promptly once confirmed. Products cancelled due to the above reasons will be permanently removed from listings across the website.

Description:

Now fully revised and in its fifth edition, the Oxford Handbook of Oncology has been the essential go-to guide for students, junior doctors, and medical professionals embarking on a career in oncology for over two decades. The handbook includes an introduction to the scientific basis and diagnosis of cancers, as well as drugs, biomarkers, and the presentation and psychosocial aspects of oncology. Concise, practical, and comprehensive, there is no better companion for both common conditions and challenging emergencies.

The field of oncology has surged forward since the last edition was published and the Oxford Handbook of Oncology has been fully revised and updated to reflect these recent advances so you can be sure that the vital information you need is in your hands. This handbook incorporates changes such as the understanding of the science of cancer, novel therapies in breast, lung, renal, and melanoma, molecular sub-classification of common solid cancers, personalized therapy approaches, new agents in hard to treat cancers, the benefits of new technologies in radiotherapy, and the increasing role of immunotherapy and targeted anti-cancer therapies.

Written by experts in the field to ensure that it is grounded in real life clinical practice, this handbook provides a concise guide to all aspects of oncology for all students, nurses, and junior faculty responsible for the care of cancer patients, while also providing further reading and highlighting areas of controversy for those who need a more detailed understanding.
Read more

Review

Review from previous edition Written by experts in the field to ensure that it is grounded in real life clinical practice, this Handbook provides a concise guide to all aspects of oncology for all students, nurses, and junior faculty responsible for the care of cancer patients, while also providing further reading and highlighting areas of controversy for those who need a more detailed understanding. ― Anticancer Research

About the Author

Miranda Payne is a previous CRUK Clinical Fellow and a current Consultant in Medical Oncology at the Oxford University Hospitals NHS Foundation Trust. Recruitment to international, academic, industry-sponsored and observational clinical trials is a routine aspect of Miranda's clinical practice, reflected in her publication record. She has a particular interest in the consequences of immunotherapy and in the systemic treatment of melanoma. She has been an editor of the Oxford Handbook of Oncology for over 20 years.


Robert Owens is a consultant clinical oncologist in Oxford where he also completed his oncology training. He specialises in treating GI cancers and has a specific interest in focussed targeted radiotherapy (SABR) especially in the upper GI setting.


Gareth Morris Stiff is an accomplished surgical oncologist with 32 years of postgraduate experience with specific expertise in hepato-pancreato-biliary (HPB) cancers, and a Pharma key opinion leader in exocrine pancreatic insufficiency. Extensive research portfolio and widely published in peer-reviewed journals. Numerous leadership roles directing teams and committees within the clinical and research arenas up to a national level. Departed clinical practice to develop anti-cancer therapies with a portfolio including antibodies, small molecules, Ayurvedic-western hybrids, and phytomedicines. Currently global chief medical officer for Equilibrium Labs developing phytomedicines to aid metabolism dysfunction-associated fatty liver disease and cancer chemotherapy-related adverse events.


Victoria Woodcock is a consultant in medical oncology specialising in the treatment of colorectal cancer. She completed her oncology training in Oxford and undertook a DPhil in Oncology at the University of Oxford studying immune responses to checkpoint inhibitor treatment in melanoma. Her academic interests include understanding and augmenting immune responses against cancer through conducting clinical trials of novel immunotherapy treatments and translational research.


Dr Rebecca Shakir is a clinical oncology consultant at the Churchill Hospital in Oxford and post-doctoral academic visitor at Oxford Population Health. Alongside treating people with head and neck and skin cancer, she specialises in the management of people with the long-term side-effects of cancer treatment. Her research focuses on determining the benefits and risks of radiotherapy and shared decision making. In addition to her clinical work, Rebecca is the Sherrington Lecturer at Magdalen College Oxford and a member of the Specialty Training and Professional Standards Boards at the Royal College of Radiologists.

Details:

Similar suggestions by Bolo

Share with

Or share with link

https://www.bolo.qa/products/K0198847165